Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TVTXTVTX
14 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in TRAVERE THERAPEUTICS INC

Yes. Qube Research & Technologies holds 1,443,230 shares of TVTX (Travere Therapeutics), worth $82M, as of its Q2 2026 13F filing. It increased the position by 774,071 shares (+115.7%) from Q1 2026. Qube Research & Technologies has held TVTX since Q4 2024, across 7 quarterly 13F filings. TVTX is 0.1% of Qube Research & Technologies' reported 13F portfolio.

Current Value

$82M

Current Shares

1.4M

Total Value Change

+$81M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+115.7%
$82M0.1%$56.81
48
2026-Q1
Increased
669,159
+64.7%
$19.9M0.0%$29.71
41
2025-Q4
Decreased
406,221
-29.0%
$15.5M0.0%$38.21
0
2025-Q3
Decreased
571,997
-5.3%
$13.7M0.0%$23.90
0
2025-Q2
Increased
604,128
+106.2%
$8.9M0.0%$14.80
44
2025-Q1
Increased
292,991
+509.9%
$5.3M0.0%$17.92
44
2024-Q4
New
48,037
-
$836,8050.0%$17.42
34
2024-Q2
Exited
0
-100.0%
$00.0%$8.22
0
2024-Q1
Decreased
15,205
-91.0%
$117,2310.0%$7.71
0
2023-Q4
New
169,114
-
$1.5M0.0%$8.99
35
2022-Q4
Exited
0
-100.0%
$00.0%$21.03
0
2022-Q3
New
11,814
-
$291,0000.0%$24.64
32
2021-Q2
Exited
0
-100.0%
$00.0%$14.59
0
2021-Q1
New
38,125
-
$952,0000.0%$24.97
35

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used